麻醉實踐中血液制品管理精要

目　錄 1　輸血和血液管理的歷史 ·········································································································1 2　現(xiàn)代血庫 ··························································································································11 3　血液成分治療 ··················································································································· 21 4　凝血系統(tǒng)和血凝塊穩(wěn)定性 ···································································································· 29 5　纖維蛋白溶解、抗纖維蛋白溶解藥物及圍手術期應用 ································································ 37 6　血液高凝與血栓性疾病 ······································································································· 51 7　血小板異常情況或疾病 ······································································································· 57 8　大量輸血方案 ··················································································································· 69 9　輔助凝血的新生物制劑 ······································································································· 81 10　影響止血的草藥··············································································································· 89 11　出血性疾病的超聲檢查 ·····································································································101 12　輸血并發(fā)癥···················································································································· 113 13　凝血系統(tǒng)疾病：血友病、血管性血友病、冷球蛋白血癥和先天性凝血因子合成障礙 ······················ 119 14　血液保護策略和免輸血醫(yī)學 ······························································································127 15　當不能選擇輸血時：對耶和華見證會信徒患者的管理 ·····························································133 16　血液替代品與人工氧載體 ·································································································139 17　貧血的術前治療··············································································································143 18　自然災難和軍事戰(zhàn)爭中血液制品管理 ··················································································151 19　影響凝血的常用處方藥：綜述 ···························································································165 20　嚴重創(chuàng)傷患者的輸血 ·······································································································189 21　圍手術期凝血床旁檢測 ····································································································199 22　血管內(nèi)皮功能障礙與炎癥狀態(tài) ···························································································213 23　產(chǎn)科患者血液管理 ··········································································································229 24　兒科患者血液管理 ··········································································································239 25　肝移植患者的血液管理 ····································································································255 26　開放性與保守性輸血策略 ·································································································265 27　遺傳性凝血功能障礙 ·······································································································275 2 麻醉實踐中血液制品管理精要 28　鐵過載的代謝、病理生理學及臨床治療 ···············································································285 29　輸血治療的陷阱··············································································································297 30　創(chuàng)傷性顱腦損傷與輸血 ····································································································309 31　輸血相關免疫調(diào)節(jié)與圍手術期感染 / 腫瘤復發(fā)：輸血相關的生理改變、證據(jù)和爭議 ·······················317 32　血液制品的來源··············································································································325 33　心臟外科的血液保護與管理 ······························································································331 34　富血小板血漿：不只是運動員的福音 ··················································································337 35　燒傷患者的輸血治療 ·······································································································345 36　院前急救輸血·················································································································349 37　全血又回來了·················································································································361 38　生理鹽水：對于出血患者并不夠生理 ··················································································367 39　老年患者的血液管理 ·······································································································371 40　藥物濫用和凝血功能障礙 ·································································································379 41　圍手術期輸注異體血液制品對癌癥復發(fā)的影響 ······································································387 42　紅細胞增多癥的圍手術期處理 ···························································································393 43　早產(chǎn)兒的血液管理 ··········································································································399 44　凝血與區(qū)域麻醉·············································································································· 411 45　鐵過載··························································································································421 46　發(fā)展中國家的血液制品管理 ······························································································425 47　接受介入性疼痛管理的患者使用抗凝和抗血栓藥物的注意事項和指南 ········································429 48　紅細胞的儲存損傷：生物學與隨機對照試驗的爭論 ································································441 彩圖···································································································································45